Bleh I don’t know how I feel about this one.
Phobias may be memories passed down in genes from ancestors
Memories may be passed down through generations in DNA in a process that may be the underlying cause of phobias
Memories can be passed down to later generations through genetic switches that allow offspring to inherit the experience of their ancestors, according to new research that may explain how phobias can develop. Scientists have long assumed that memories and learned experiences built up during a lifetime must be passed on by teaching later generations or through personal experience. However, new research has shown that it is possible for some information to be inherited biologically through chemical changes that occur in DNA. Researchers at the Emory University School of Medicine, in Atlanta, found that mice can pass on learned information about traumatic or stressful experiences – in this case a fear of the smell of cherry blossom – to subsequent generations. The results may help to explain why people suffer from seemingly irrational phobias – it may be based on the inherited experiences of their ancestors. (via Phobias may be memories passed down in genes from ancestors - Telegraph)
HIV: First pediatric vaccination of Vertically Infected Children in Italy - First Pediatric Randomised Trial (PEDVAC).
A pediatric vaccination was successfully tested on twenty vertically HIV-infected children, 6–16 years of age, with stable viral load control and CD4+ values above 400 cells/mm3, at the Pediatric Hospital of the Child Jesus in Rome.
The research is published on PLOS one and it was led by immunologist Paolo Palma, from Paolo Rossi’s team.
Ten subjects continued their ongoing antiretroviral treatment (ART) and ten were immunized with a HIV-DNA vaccine in addition to their previous therapy (ART and vaccine). The genetic vaccine represented HIV-1 subtypes A, B and C, encoded Env, Rev, Gag and RT and had no additional adjuvant. Immunizations took place at weeks 0, 4 and 12, with a boosting dose at week 36. Monitoring was performed until week 60 and extended to week 96.
The study demonstrates the feasibility, safety and moderate immunogenicity of genetic vaccination in vertically HIV-infected children, paving the way for amplified immunotherapeutic approaches in the pediatric population.
To read more: PLOS one link.
"She was half his family…"